Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Braze Inc (BRZE) Price & Performance

AbCellera Biologics IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Braze Inc — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Braze Inc trades at $28.06 (market cap $3.18B). The key difference: AbCellera Biologics Inc and Braze Inc are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Braze Inc nearer its low. Which is the better fit depends on your goals.

ABCLBRZE
Market Cap
$2.99B$3.18B
Sector
HealthTechnology
52-Week High
$9.76$36.19
52-Week Low
$2.78$15.79
Enterprise Value
$2.58B$2.87B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Braze Inc

Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries.

Read more on BRZE